南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

功能化脱细胞纤维软骨基质移植物促进肩袖止点再生的新策略

Functional decellularized fibrocartilaginous matrix graft for rotator cuff enthesis regeneration: A novel technique to avoid in-vitro loading of cells

Can Chen, Yang Chen, Muzh Li, Han Xiao, Qiang Shi, Tao Zhang, Xing Li, Chunfeng Zhao, Jianzhong Hu, Hongbin Lu

Journal:BIOMATERIALS

IF:10.32

DOI:10.1016/j.biomaterials.2020.119996

PMID:32334201

Published:2020-04-17

research field:神经科学生物材料再生医学免疫调节纳米医学干细胞治疗

Abstract

Rapid and functional enthesis regeneration after rotator cuff tear (RCT) remains a challenge in clinic. Current tissue-engineering strategies for solving this challenge are focused on developing grafts with the mode of in-vitro loading cells on a scaffold. However, this mode is complicated and time-inefficient, moreover the preservation of this graft outside a cell incubator is highly inconvenient, thus limiting their clinical application. Developing a cell-free graft with chemotaxis to recruit postoperative injected cells may be a promising approach to solve these problems. Herein, we prepared a recombinant SDF-1α (termed as C-SDF-1α) capable of binding collagen and chemotaxis, which were then tethered on the collagen fibers of book-shaped decellularized fibrocartilage matrix (BDFM) to fabricate this cell-free graft (C-SDF-1α/BDFM). This C-SDF-1α/BDFM is noncytotoxicity and low-immunogenicity, allows synovium-derived mesenchymal stem cells (SMSCs) attachment and proliferation, and shows superior chondrogenic inducibility. More importantly, C-SDF-1α/BDFM released the tethered SDF-1α with a sustained release profile in-vitro and in-vivo, thus steadily recruiting chemokine (C-X-C motif) receptor 4 positive (CXCR4 + ) cells. Rats with RCT were repaired acutely with C-SDF-1α/BDFM together with postoperative CXCR4 + SMSCs injection (C-SDF-1α/BDFM + CXCR4 + SMSCs), BDFM in-vitro pre-loaded CXCR4 + SMSCs (BDFM/CXCR4 + SMSCs), or direct suture only (CTL). At postoperative 14-day, compared with BDFM/CXCR4 + SMSCs, C-SDF-1α/BDFM + CXCR4 + SMSCs showed a little more CXCR4 + SMSCs at the healing site. At postoperative week 4 or 8, rats treated with C-SDF-1α/BDFM + CXCR4 + SMSCs presented a similar RC healing quality as BDFM/CXCR4 + SMSCs, both of which were significantly better than the CTL. Collectively, compared with conventional BDFM/CXCR4 + SMSCs, C-SDF-1α/BDFM, as a cell-free graft with chemotaxis, could recruit postoperative injected CXCR4 + cells into the heal

本文使用的Yeasen产品

购物车
客服
转染试用